Home
>
National Drug Code (NDC)
>
Quasense
Quasense - 52544-966-91 - (Levonorgestrel and Ethinyl Estradiol)
Drug Information of Quasense
| Product NDC: | 52544-966 |
| Proprietary Name: | Quasense |
| Non Proprietary Name: | Levonorgestrel and Ethinyl Estradiol |
| Active Ingredient(s): | & nbsp; Levonorgestrel and Ethinyl Estradiol |
| Administration Route(s): | ORAL |
| Dosage Form(s): | KIT |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Quasense
| Product NDC: | 52544-966 |
| Labeler Name: | Watson Pharma, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA077101 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20060906 |
Package Information of Quasense
| Package NDC: | 52544-966-91 |
| Package Description: | 1 KIT in 1 CARTON (52544-966-91) |
NDC Information of Quasense
| NDC Code | 52544-966-91 |
| Proprietary Name | Quasense |
| Package Description | 1 KIT in 1 CARTON (52544-966-91) |
| Product NDC | 52544-966 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Levonorgestrel and Ethinyl Estradiol |
| Dosage Form Name | KIT |
| Route Name | ORAL |
| Start Marketing Date | 20060906 |
| Marketing Category Name | ANDA |
| Labeler Name | Watson Pharma, Inc. |
| Substance Name | |
| Strength Number | |
| Strength Unit | |
| Pharmaceutical Classes |
